An observational cohort study of the risk of thromboembolic events among adult patients treated with KCENTRA® compared with plasma for urgent reversal of vitamin K antagonist therapy in the setting of acute major bleeding (REVERSAL) | HMA-EMA Catalogues of real-world data sources and studies